Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.275 AUD | -1.79% | -5.17% | +44.74% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Howie McKibbon
CEO | Chief Executive Officer | - | 19-04-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
Chief Tech/Sci/R&D Officer | 68 | 21-02-28 | |
Henry Bosch
BRD | Director/Board Member | - | 16-06-30 |
Jack Hoblitzell
PRN | Corporate Officer/Principal | - | 21-09-23 |
Anthony Robinson
PRN | Corporate Officer/Principal | - | 21-02-28 |
Susan Park
SEC | Corporate Secretary | 49 | 23-04-16 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Stewart Washer
BRD | Director/Board Member | 54 | 19-02-20 |
Henry Bosch
BRD | Director/Board Member | - | 16-06-30 |
Vincent Ippolito
CHM | Chairman | 65 | 19-05-19 |
Matthew Callahan
FOU | Founder | 51 | 16-06-30 |
Daniel Sharp
BRD | Director/Board Member | - | 22-03-21 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 1,547,144,642 | 1,319,431,449 ( 85.28 %) | 0 | 85.28 % |
Company contact information
Botanix Pharmaceuticals Ltd.
661 Newcastle Street Unit D2
6007, Leederville
+
http://www.botanixpharma.comSector
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+44.74% | 285M | |
+19.29% | 80.5B | |
+15.08% | 9.15B | |
-18.33% | 4.9B | |
+43.39% | 4.49B | |
+13.95% | 4.44B | |
+10.89% | 2.19B | |
-28.40% | 2.13B | |
+15.93% | 2.1B | |
-43.17% | 1.78B |
- Stock Market
- Equities
- BOT Stock
- Company Botanix Pharmaceuticals Limited